Michael is the Head of Worldwide Government Affairs and Policy for Organon, a US-based multi-national biopharmaceutical company that is the world’s largest MNC focused on improving the health of women. As a founding executive of the multi-billion-dollar Fortune 500 startup, he directs global strategic policy-shaping efforts across the full portfolio of Women’s Health, Biosimilars and Legacy Brands franchises, leads government affairs activities, including US Federal and State actions as well as international efforts, and oversees the strategic alignment of Organon’s comprehensive Environmental Social and Governance (ESG) program with policy-shaping activities, with a focus on Access to Medicine.
Secretary GeneralOrganisation pour de Nouvelles Initiatives en Développement et Santé (ONIDS) [Organisation for New Initiatives in Development and Health]
Executive DirectorOrganisation pour de Nouvelles Initiatives en Développement et Santé (ONIDS) [Organisation for New Initiatives in Development and Health]
President of the Senegal branch of ROAJELFRéseau Ouest Africain des Jeunes Femmes Leaders (ROAJELF) [West African Network of Young Women Leaders] Senegal branch
Youth Focal Point for Partenariat de Ouagadougou [Ouagadougou Partnership] / Family Planning FP 2030Partenariat de Ouagadougou [Ouagadougou Partnership] / Family Planning 2030
We collect cookies necessary for the operation of the website. Your consent to our privacy policy including cookies’ collection and utilization will be required upon your registration only. For further information, check the privacy policy.